<DOC>
	<DOCNO>NCT02913729</DOCNO>
	<brief_summary>Most local recurrence ( LR ) find breast-conserving therapy within close tumor bed . This pattern recurrence confirm study breast conserve surgery without adjuvant irradiation update NSABP B-06 trial . In EORTC boost trial , however , 29 % LR find outside area original tumor . Still , recent review Breast Conserving Therapy ( BCT ) trial show site local recurrence BCT mostly tumor bed , le 10 % LR elsewhere breast . This lead concept partial breast irradiation . With accelerated partial breast irradiation ( APBI ) , limited volume breast tissue irradiate , allow high dose per fraction compare whole breast irradiation ( WBI ) , favorable consider low alpha/beta ratio , thus high sensitivity high dose per fraction .</brief_summary>
	<brief_title>Pre- Versus Postoperative Accelerated Partial Breast Irradiation</brief_title>
	<detailed_description>Patients undergo partial accelerate breast irradiation pre-or postoperative 5 x 5.7 Gy</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female patient ≥ 51 year clinical stage tumor12 ( ≤ 3 cm ) cN0 Grade I grade II ( biopsy ) Histologically proven invasive ductal adenocarcinoma Unifocal lesion mammogram MRI ( small satellite lesion adjacent tumor accept long suitable local excision determine participate centre ) World Health Organization performance status ≤ 2 Life expectancy ≥ 5 year Written inform consent Distant metastases Lobular invasive carcinoma Pure Ductal Carcinoma situ ( DCIS ) without invasive tumor Grade III biopsy Triple negative tumor HER2neu positive tumor Lymphvascular invasion biopsy TNM pathologic stage N13 Multicentric / multifocal disease mammogram MRI Diffuse calcification mammogram ( Birads 3 , 4 5 ) Prior treatment protocol tumor ( surgery , neoadjuvant chemotherapy neoadjuvant hormonal therapy , previous radiotherapy ) Previous contralateral breast cancer Other neoplasm last 5 year exception : Basal cell carcinoma skin Adequately treat carcinoma situ cervix Planned oncoplastic resection tissue displacement</criteria>
	<gender>Female</gender>
	<minimum_age>51 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>breast cancer</keyword>
</DOC>